Eli Lilly Split Scenario: Market Depth and New Supply

Eli Lilly shares are marching confidently towards a long-speculated stock split, driven by record pricing and heightened volatility in market depth. High-frequency algorithms and market makers have already begun pricing in this structural shift in the company's valuation dynamics.

Dominance in Obesity Treatments

■Global demand for weight-loss drugs like Mounjaro and Zepbound has pushed the company's market cap above $800 billion, placing it among the world's most valuable companies.

■Investors are increasing pressure for a split as the share price exceeds $800, aiming for increased liquidity and a broader investor base.

■Analysts predict that the split could create a volatility surge of up to 20% in trading volume by enhancing the stock's accessibility.

HFT Indicators and Market Structure

■An abnormal 15% surge in retail demand was detected in broker distributions over the last 24 hours, indicating that small investors are positioning themselves ahead of the split.

■The sharp rise in dark pool volumes suggests institutional investors are rebalancing their positions with block trades against the new price ranges that will emerge post-split.

■Data tracking smart money reveals that large funds are using buy-side pressure to force liquidity squeezes on market makers.

Volkan Şen: Smart money knows that split news typically brings a short-term rally, but the real gain stems from the increase in liquidity in the market structure. The depth in Eli Lilly is creating an ideal field for algorithmic trading; specifically, this concentration in dark pool activity proves that the price discovery mechanism is already at work ahead of the split.